Table 3: Relationship between HLA alleles and AQP4 autoantibodies in NMO patients.
| Allele frequencies (%) | ||||
| HLA | Alleles | *N = 8 | **N = 12 | P value |
| DRB1* | 03:01 | 25 | 10 | 0.21 |
| 15:01 - 15:02 | 5 | 5 | 0.7 | |
| 01:01 - 01:03 | 0 | 0 | 0.7 | |
| 01:02 | 0 | 0 | 0.7 | |
| 07:01 - 07:02 | 15 | 5 | 0.3 | |
| 10:01 | 5 | 0 | 0.5 | |
| 11:01 - 11:04 | 15 | 25 | 0.2 | |
| 14:01 - 14:04 | 0 | 0 | 0.7 | |
| 14:03 | 5 | 10 | 0.4 | |
| DQA1* | 03:01 | 0 | 10 | 0.24 |
| 01:02 | 15 | 10 | 0.57 | |
| DQB1* | 06:02 | 5 | 5 | 0.7 |
*N: Number of patients with autoantibodies against AQP4, **N: Number of patients without autoantibodies against AQP4.